GON TECHNOLOGY (02768) will conduct its initial public offering from January 27 to January 30, 2026. The company plans a global offering of 30 million shares, with 10% allocated for the Hong Kong public offering and 90% for the international offering. An additional 15% over-allotment option is included. The offer price is set between HK$34.00 and HK$42.00 per share, with a board lot size of 200 shares. The shares are expected to commence trading on the Stock Exchange on February 4, 2026.

The company is a Chinese supplier specializing in chemical new materials, gelatin, and upstream and downstream collagen products. It serves the chemical industry and the health and wellness sector, primarily engaging in the research and development, production, and sales of products for industrial and commercial use. For its major chemical segment, the company's clientele includes manufacturers from downstream industries such as automotive, new energy, and home appliances, as well as supply chain solution providers for these manufacturers. For its health and wellness segment, its customers are mainly medical and pharmaceutical manufacturers who utilize the company's products as raw materials for producing downstream items like supplements and medicines.

The net proceeds to be received by the company are estimated to be approximately HK$1.058 billion, assuming an offer price of HK$38.00 per H-share, which is the midpoint of the indicative price range. Roughly 50.0% of the net proceeds will be allocated to expanding the production capacity of the company's new production base in Thailand. Approximately 35.0% will be designated for expanding the capacity of the company's new production base in China. About 10.0% will be allocated to the company's investments in Hong Kong, including the establishment of a regional headquarters and upgrades to production facilities. The remaining 5.0% of the net proceeds will be used for working capital and general corporate purposes.